Atlas Trials

PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma

Clinical trial NCT07256158 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07256158
Sponsor
Fondazione Italiana Linfomi - ETS
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hodgkin Lymphoma
Start date
2026-03-01
Primary completion
2033-03-01
Enrollment
518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.